Solomon Cohney

Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand

Lucy C Fox, Solomon J Cohney, Joshua Y Kausman, Jake Shortt, Peter D Hughes, Erica M Wood, Nicole M Isbel, Theo de Malmanche, Anne Durkan, Pravin Hissaria, Piers Blombery, Thomas D Barbour

Journal article  |  2018  |  INTERNAL MEDICINE JOURNAL

Thrombotic microangiopathy (TMA) arises in a variety of clinical circumstances with the potential to cause significant dysfunction..

Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand

Lucy C Fox, Solomon J Cohney, Joshua Y Kausman, Jake Shortt, Peter D Hughes, Erica M Wood, Nicole M Isbel, Theo de Malmanche, Anne Durkan, Pravin Hissaria, Piers Blombery, Thomas D Barbour

Journal article  |  2018  |  NEPHROLOGY

Thrombotic microangiopathy (TMA) arises in a variety of clinical circumstances with the potential to cause significant dysfunction..

Overcoming preexisting alloantibody in renal transplantationimproving outcomes while reducing needs and costs

A Bentall, Solomon J Cohney

Journal article  |  2017  |  AMERICAN JOURNAL OF TRANSPLANTATION

New Pharmacologic Agents That Target Inflammation and Fibrosis in Nonalcoholic Steatohepatitis-Related Kidney Disease

Giovanni Musso, Franco De Michieli, Daria Bongiovanni, Renato Parente, Luciana Framarin, Nicola Leone, Mara Berrutti, Roberto Gambino, Maurizio Cassader, Solomon Cohney, Elena Paschetta

Journal article  |  2017  |  CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

Epidemiologic data show an association between the prevalence and severity of nonalcoholic fatty liver disease and the incidence a..

Histological and Extended Clinical Outcomes After ABO-Incompatible Renal Transplantation Without Splenectomy or Rituximab

Kevin V Chow, Shaun M Flint, Angeline Shen, Anthony Landgren, Moira Finlay, Anand Murugasu, Rosemary Masterson, Peter Hughes, Solomon J Cohney

Journal article  |  2017  |  TRANSPLANTATION

BACKGROUND: Excellent short-term results have been reported in ABO-incompatible (ABOi) renal transplant recipients managed solely ..

Fatty Liver and Chronic Kidney Disease: Novel Mechanistic Insights and Therapeutic Opportunities

Giovanni Musso, Maurizio Cassader, Solomon Cohney, Franco De Michieli, Silvia Pinach, Francesca Saba, Roberto Gambino

Journal article  |  2016  |  DIABETES CARE

Chronic kidney disease (CKD) is a risk factor for end-stage renal disease (ESRD) and cardiovascular disease (CVD). ESRD or CVD dev..

Post-transplantation diabetes-state of the art

Adnan Sharif, Solomon Cohney

Journal article  |  2016  |  LANCET DIABETES & ENDOCRINOLOGY

With increasing success in overcoming the immunological and infectious challenges accompanying solid organ transplantation, suscep..

Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia: findings from the first 5 years of the Australian TTP/thrombotic microangiopathy registry

P Blombery, L Kivivali, D Pepperell, Z McQuilten, S Engelbrecht, MN Polizzotto, LE Phillips, E Wood, S Cohney

Journal article  |  2016  |  INTERNAL MEDICINE JOURNAL

BACKGROUND: Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening thrombotic microangiopathy (TMA). In 2009, the A..

Cancer-Specific and All-Cause Mortality in Kidney Transplant Recipients With and Without Previous Cancer

Andrea K Viecelli, Wai H Lim, Petra Macaskill, Jeremy R Chapman, Jonathan C Craig, Philip Clayton, Solomon Cohney, Robert Carroll, Germaine Wong

Journal article  |  2015  |  TRANSPLANTATION

BACKGROUND: For dialysis patients with a cancer history, a period of surveillance is generally recommended before listing for tran..

Emerging Liver-Kidney Interactions in Nonalcoholic Fatty Liver Disease

Giovanni Musso, Maurizio Cassader, Solomon Cohney, Silvia Pinach, Francesca Saba, Roberto Gambino

Journal article  |  2015  |  TRENDS IN MOLECULAR MEDICINE

Mounting evidence connects non-alcoholic fatty liver disease (NAFLD) to chronic kidney disease (CKD). We review emerging mechanist..